Blood pressure regulation by ETA and ETB receptors in conscious, telemetry-instrumented mice and role of ETA in hypertension produced by selective ETB blockade

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 6, 2006, Pages

  Fryer, Ryan M ^a   Rakestraw, Pamela A ^a   Banfor, Patricia N ^a   Cox, Bryan F ^a   Opgenorth, Terry J ^a   Reinhart, Glenn A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

A 192621; Atrasentan; Endothelin; Mouse; Vasculature

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ATRASENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; HYPERTENSION; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TELEMETRY;

ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HYPERTENSION; MICE; MICE, INBRED C57BL; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; TELEMETRY;

EID: 33744918043     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01221.2005     Document Type: Article

References (42)

1. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, Hughes AK, Yanagisawa M, Miller L, Nelson RD, and Kohan DE. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 114: 504-511, 2004.
2. Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
3. Berthold H, Munter K, Just A, Kirchheim HR, and Ehmke H. Stimulation of the renin-angiotensin system by endothelin subtype A receptor blockade in conscious dogs. Hypertension 33: 1420-1424, 1999.
4. Cholewa BC, Meister CJ, and Mattson DL. Importance of the renin-angiotensin system in the regulation of arterial blood pressure in conscious mice and rats. Acta Physiol Scand 183: 309-320, 2005.
5. A receptor. J Biol Chem 270: 10855-10860, 1995.
6. Clavell AL, Stingo AJ, Margulies KB, Brandt RR, and Burnett JC Jr. Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol Renal Fluid Electrolyte Physiol 268: F455-F460, 1995.
7. Cornet S, Pirotzky E, and Braquet P. Implication of different endothelin receptors in the vascular action of a hypertensive dose of ET-1 in rat. J Cardiovasc Pharmacol 22, Suppl 8: S239-S242, 1993.
8. Douglas SA, Sulpizio AC, Piercy V, Sarau HM, Ames RS, Aiyar NV, Ohlstein EH, and Willette RN. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131: 1262-1274, 2000.
9. B receptor-deficient rats. J Cardiovasc Pharmacol 44: S7-S10, 2004.
10. Garcia NH and Garvin JL. Endothelin's biphasic effect on fluid absorption in the proximal straight tubule and its inhibitory cascade. J Clin Invest 93: 2572-2577, 1994.
11. Gariepy CE, Cass DT, and Yanagisawa M. Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci USA 93: 867-872, 1996.
12. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, and Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933, 2000.
13. Ge Y, Stricklett PK, Hughes AK, Yanagisawa M, and Kohan DE. Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure. Am J Physiol Renal Physiol 289: F692-F698, 2005.
14. Gomez-Alamillo C, Juncos LA, Cases A, Haas JA, and Romero JC. Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds. Hypertension 42: 831-836, 2003.
15. Goto K, Hama H, and Kasuya Y. Molecular pharmacology and pathophysiological significance of endothelin. Jpn J Pharmacol 72: 261-290, 1996.
16. Granger JP. Endothelin. Am J Physiol Regul Integr Comp Physiol 285: R298-R301, 2003.
17. Harris PJ, Zhuo J, Mendelsohn FA, and Skinner SL. Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats. J Physiol 433: 25-39, 1991.
18. Haynes WG and Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 16: 1081-1098, 1998.
19. Hoffman A, Abassi ZA, Brodsky S, Ramadan R, and Winaver J. Mechanisms of big endothelin-1-induced diuresis and natriuresis: role of ET(B) receptors. Hypertension 35: 732-739, 2000.
20. Kotelevtsev Y and Webb DJ. Endothelin as a natriuretic hormone: the case for a paracrine action mediated by nitric oxide. Cardiovasc Res 51: 481-488, 2001.
21. Kramer BK, Ittner KP, Beyer ME, Hoffmeister HM, and Riegger GA. Circulatory and myocardial effects of endothelin. J Mol Med 75: 886-890, 1997.
22. Kuwaki T, Ishii T, Ju K, Yanagisawa M, and Fukuda Y. Blood pressure of endothelin-3 null (-/-) knockout mice and endothelin A receptor null (-/-) knockout mice under anaesthesia. Clin Sci (Lond) 103, Suppl 48: 48S-52S, 2002.
23. Lavallee M and Thorin E. Role of ET-1 in the regulation of coronary circulation. Can J Physiol Pharmacol 81: 570-577, 2003.
24. Masaki T, Ninomiya H, Sakamoto A, and Okamoto Y. Structural basis of the function of endothelin receptor. Mol Cell Biochem 190: 153-156, 1999.
25. McNeill JR. Role of endothelin in regulation of resistance, fluid-exchange, and capacitance functions of the systemic circulation. Can J Physiol Pharmacol 81: 522-532, 2003.
26. Miyauchi T and Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61: 391-415, 1999.
27. Munter K, Ehmke H, and Kirchengast M. Maintenance of blood pressure in normotensive dogs by endothelin. Am J Physiol Heart Circ Physiol 276: H1022-H1027, 1999.
28. B receptor in mice. Am J Physiol Regul Integr Comp Physiol 276: R1071-R1077, 1999.
29. B receptor-mediated NO release. Am J Physiol Renal Physiol 279: F326-F333, 2000.
30. B deficiency in renal responses to big ET-1. Physiol Genomics 6: 39-43, 2001.
31. Pollock DM and Pollock JS. Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol 281: F144-F150, 2001.
32. A receptors. Am J Physiol Heart Circ Physiol 283: H1555-H1561, 2002.
33. A receptors in long-term arterial pressure homeostasis in conscious nonhuman primates. Am J Physiol Regul Integr Comp Physiol 279: R1701-R1706, 2000.
34. Russell A and Watts S. Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse. J Pharmacol Exp Ther 294: 598-604, 2000.
35. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
36. Sandgaard NC and Bie P. Natriuretic effect of non-pressor doses of endothelin-1 in conscious dogs. J Physiol 494: 809-818, 1996.
37. Schiffrin EL. Endothelin and endothelin antagonists in hypertension. J Hypertens 16: 1891-1895, 1998.
38. B receptors in canine coronary arteries. Circ Res 74: 105-114, 1994.
39. B selectivity. J Med Chem 42: 3668-3678, 1999.
40. Warner TD. Characterization of endothelin synthetic pathways and receptor subtypes: physiological and pathophysiological implications. Eur Heart J 14, Suppl I: 42-47, 1993.
41. Wiley KE and Davenport AP. Endothelin receptor pharmacology and function in the mouse: comparison with rat and man. J Cardiovasc Pharmacol 44, Suppl 1: S4-S6, 2004.
42. A receptor antagonist, on blood pressure in normotensive and hypertensive rats. Vascul Pharmacol 41: 27-34, 2004.